# Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia

> **NCT02862210** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 17 (actual)

## Conditions studied

- Frontotemporal Dementia (FTD)

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02862210
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-27
- **Primary completion:** 2022-11-20
- **Final completion:** 2022-11-20
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862210, "Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02862210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*